Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Mayo Clinic Laboratories, |
RCV004792312 | SCV005413173 | likely pathogenic | not provided | 2024-01-23 | criteria provided, single submitter | clinical testing | PM2_moderate, PVS1_strong |
Athena Diagnostics | RCV004792312 | SCV005620765 | pathogenic | not provided | 2024-04-05 | criteria provided, single submitter | clinical testing | This variant is not expected to cause loss of protein expression through nonsense-mediated decay, however, similar variants in this region have been associated with hereditary neuropathy with liability to pressure palsies (HNPP), and therefore, this variant is also expected to associate with HNPP. This variant has been identified in at least one individual tested at Athena Diagnostics with clinical features associated with this gene. This variant has not been reported in large, multi-ethnic general populations. (http://gnomad.broadinstitute.org) |